Calidi Net Income From Continuing Ops from 2010 to 2026
| CLDI Stock | 1.02 0.02 1.92% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -20 M | Current Value -21 M | Quarterly Volatility 7.1 M |
Check Calidi Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Calidi Biotherapeutics' main balance sheet or income statement drivers, such as Tax Provision of 13.6 K, Depreciation And Amortization of 1.9 M or Interest Expense of 1.2 M, as well as many indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.14 or PTB Ratio of 5.65. Calidi financial statements analysis is a perfect complement when working with Calidi Biotherapeutics Valuation or Volatility modules.
Calidi | Net Income From Continuing Ops | Build AI portfolio with Calidi Stock |
Latest Calidi Biotherapeutics' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Calidi Biotherapeutics over the last few years. It is Calidi Biotherapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Calidi Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Calidi Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (12,458,859) | |
| Coefficient Of Variation | (57.05) | |
| Mean Deviation | 6,031,331 | |
| Median | (7,937,000) | |
| Standard Deviation | 7,107,442 | |
| Sample Variance | 50.5T | |
| Range | 21.3M | |
| R-Value | (0.77) | |
| Mean Square Error | 21.9T | |
| R-Squared | 0.59 | |
| Significance | 0.0003 | |
| Slope | (1,084,972) | |
| Total Sum of Squares | 808.3T |
Calidi Net Income From Continuing Ops History
About Calidi Biotherapeutics Financial Statements
Investors use fundamental indicators, such as Calidi Biotherapeutics' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Calidi Biotherapeutics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Loss | -20 M | -21 M |
Currently Active Assets on Macroaxis
When determining whether Calidi Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Calidi Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calidi Biotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calidi Biotherapeutics Stock:Check out the analysis of Calidi Biotherapeutics Correlation against competitors. For more detail on how to invest in Calidi Stock please use our How to Invest in Calidi Biotherapeutics guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Calidi Biotherapeutics. If investors know Calidi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Calidi Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Calidi Biotherapeutics is measured differently than its book value, which is the value of Calidi that is recorded on the company's balance sheet. Investors also form their own opinion of Calidi Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Calidi Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Calidi Biotherapeutics' market value can be influenced by many factors that don't directly affect Calidi Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Calidi Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Calidi Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Calidi Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.